Logo image of ARAMI.PA

ARAMIS GROUP SAS (ARAMI.PA) Stock Fundamental Analysis

EPA:ARAMI - Euronext Paris - Matif - FR0014003U94 - Common Stock - Currency: EUR

7.85  +0.11 (+1.42%)

Fundamental Rating

5

ARAMI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 53 industry peers in the Specialty Retail industry. ARAMI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ARAMI is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ARAMI was profitable.
ARAMI had a positive operating cash flow in the past year.
In the past 5 years ARAMI reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: ARAMI reported negative operating cash flow in multiple years.
ARAMI.PA Yearly Net Income VS EBIT VS OCF VS FCFARAMI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

ARAMI has a better Return On Assets (4.38%) than 79.25% of its industry peers.
The Return On Equity of ARAMI (13.95%) is better than 77.36% of its industry peers.
ARAMI has a Return On Invested Capital of 7.94%. This is in the better half of the industry: ARAMI outperforms 73.58% of its industry peers.
Industry RankSector Rank
ROA 4.38%
ROE 13.95%
ROIC 7.94%
ROA(3y)-5.25%
ROA(5y)-3.85%
ROE(3y)-14.17%
ROE(5y)-10.18%
ROIC(3y)N/A
ROIC(5y)N/A
ARAMI.PA Yearly ROA, ROE, ROICARAMI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

With a Profit Margin value of 1.16%, ARAMI perfoms like the industry average, outperforming 58.49% of the companies in the same industry.
In the last couple of years the Profit Margin of ARAMI has declined.
ARAMI has a Operating Margin (1.50%) which is in line with its industry peers.
In the last couple of years the Operating Margin of ARAMI has declined.
ARAMI's Gross Margin of 17.27% is on the low side compared to the rest of the industry. ARAMI is outperformed by 81.13% of its industry peers.
ARAMI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.5%
PM (TTM) 1.16%
GM 17.27%
OM growth 3YN/A
OM growth 5Y-19.06%
PM growth 3YN/A
PM growth 5Y-19.13%
GM growth 3Y-1.55%
GM growth 5Y-0.07%
ARAMI.PA Yearly Profit, Operating, Gross MarginsARAMI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ARAMI is creating some value.
Compared to 1 year ago, ARAMI has about the same amount of shares outstanding.
The number of shares outstanding for ARAMI remains at a similar level compared to 5 years ago.
ARAMI has a better debt/assets ratio than last year.
ARAMI.PA Yearly Shares OutstandingARAMI.PA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ARAMI.PA Yearly Total Debt VS Total AssetsARAMI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 4.83 indicates that ARAMI is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.83, ARAMI belongs to the top of the industry, outperforming 94.34% of the companies in the same industry.
ARAMI has a debt to FCF ratio of 3.69. This is a good value and a sign of high solvency as ARAMI would need 3.69 years to pay back of all of its debts.
ARAMI has a Debt to FCF ratio of 3.69. This is in the better half of the industry: ARAMI outperforms 71.70% of its industry peers.
A Debt/Equity ratio of 0.57 indicates that ARAMI is somewhat dependend on debt financing.
ARAMI's Debt to Equity ratio of 0.57 is in line compared to the rest of the industry. ARAMI outperforms 49.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 3.69
Altman-Z 4.83
ROIC/WACC1.15
WACC6.93%
ARAMI.PA Yearly LT Debt VS Equity VS FCFARAMI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

ARAMI has a Current Ratio of 1.24. This is a normal value and indicates that ARAMI is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.24, ARAMI perfoms like the industry average, outperforming 56.60% of the companies in the same industry.
ARAMI has a Quick Ratio of 1.24. This is a bad value and indicates that ARAMI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.42, ARAMI is not doing good in the industry: 67.92% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 0.42
ARAMI.PA Yearly Current Assets VS Current LiabilitesARAMI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 186.52% over the past year.
ARAMI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.86% yearly.
ARAMI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.90%.
Measured over the past years, ARAMI shows a very strong growth in Revenue. The Revenue has been growing by 24.72% on average per year.
EPS 1Y (TTM)186.52%
EPS 3YN/A
EPS 5Y0.86%
EPS Q2Q%147.95%
Revenue 1Y (TTM)11.9%
Revenue growth 3Y20.97%
Revenue growth 5Y24.72%
Sales Q2Q%10.47%

3.2 Future

The Earnings Per Share is expected to grow by 111.03% on average over the next years. This is a very strong growth
ARAMI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.41% yearly.
EPS Next Y305.86%
EPS Next 2Y152.67%
EPS Next 3Y111.04%
EPS Next 5YN/A
Revenue Next Year8.18%
Revenue Next 2Y8.72%
Revenue Next 3Y8.76%
Revenue Next 5Y5.41%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ARAMI.PA Yearly Revenue VS EstimatesARAMI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
ARAMI.PA Yearly EPS VS EstimatesARAMI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6 0.8

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 23.79, which indicates a rather expensive current valuation of ARAMI.
Compared to the rest of the industry, the Price/Earnings ratio of ARAMI indicates a somewhat cheap valuation: ARAMI is cheaper than 71.70% of the companies listed in the same industry.
ARAMI is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.43, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 15.66, the valuation of ARAMI can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ARAMI indicates a somewhat cheap valuation: ARAMI is cheaper than 71.70% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ARAMI to the average of the S&P500 Index (22.17), we can say ARAMI is valued slightly cheaper.
Industry RankSector Rank
PE 23.79
Fwd PE 15.66
ARAMI.PA Price Earnings VS Forward Price EarningsARAMI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

ARAMI's Enterprise Value to EBITDA ratio is in line with the industry average.
66.04% of the companies in the same industry are more expensive than ARAMI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.59
EV/EBITDA 11.25
ARAMI.PA Per share dataARAMI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

ARAMI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ARAMI's earnings are expected to grow with 111.03% in the coming years.
PEG (NY)0.08
PEG (5Y)27.64
EPS Next 2Y152.67%
EPS Next 3Y111.04%

0

5. Dividend

5.1 Amount

No dividends for ARAMI!.
Industry RankSector Rank
Dividend Yield N/A

ARAMIS GROUP SAS

EPA:ARAMI (6/5/2025, 4:51:35 PM)

7.85

+0.11 (+1.42%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-19 2025-05-19
Earnings (Next)07-24 2025-07-24
Inst Owners8.4%
Inst Owner ChangeN/A
Ins Owners17.85%
Ins Owner ChangeN/A
Market Cap650.45M
Analysts82.67
Price Target10.27 (30.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)9.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)5.38%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 23.79
Fwd PE 15.66
P/S 0.28
P/FCF 12.59
P/OCF 10.17
P/B 3.33
P/tB 8.87
EV/EBITDA 11.25
EPS(TTM)0.33
EY4.2%
EPS(NY)0.5
Fwd EY6.39%
FCF(TTM)0.62
FCFY7.94%
OCF(TTM)0.77
OCFY9.83%
SpS28.39
BVpS2.36
TBVpS0.88
PEG (NY)0.08
PEG (5Y)27.64
Profitability
Industry RankSector Rank
ROA 4.38%
ROE 13.95%
ROCE 10.8%
ROIC 7.94%
ROICexc 8.78%
ROICexgc 14.94%
OM 1.5%
PM (TTM) 1.16%
GM 17.27%
FCFM 2.2%
ROA(3y)-5.25%
ROA(5y)-3.85%
ROE(3y)-14.17%
ROE(5y)-10.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-18.03%
ROICexc growth 3YN/A
ROICexc growth 5Y-18.92%
OM growth 3YN/A
OM growth 5Y-19.06%
PM growth 3YN/A
PM growth 5Y-19.13%
GM growth 3Y-1.55%
GM growth 5Y-0.07%
F-Score8
Asset Turnover3.78
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 3.69
Debt/EBITDA 1.57
Cap/Depr 34.28%
Cap/Sales 0.52%
Interest Coverage 3.1
Cash Conversion 89.87%
Profit Quality 189.68%
Current Ratio 1.24
Quick Ratio 0.42
Altman-Z 4.83
F-Score8
WACC6.93%
ROIC/WACC1.15
Cap/Depr(3y)68.65%
Cap/Depr(5y)66.64%
Cap/Sales(3y)1.02%
Cap/Sales(5y)0.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)186.52%
EPS 3YN/A
EPS 5Y0.86%
EPS Q2Q%147.95%
EPS Next Y305.86%
EPS Next 2Y152.67%
EPS Next 3Y111.04%
EPS Next 5YN/A
Revenue 1Y (TTM)11.9%
Revenue growth 3Y20.97%
Revenue growth 5Y24.72%
Sales Q2Q%10.47%
Revenue Next Year8.18%
Revenue Next 2Y8.72%
Revenue Next 3Y8.76%
Revenue Next 5Y5.41%
EBIT growth 1Y270.85%
EBIT growth 3YN/A
EBIT growth 5Y0.94%
EBIT Next Year6489.46%
EBIT Next 3Y403.91%
EBIT Next 5Y180.37%
FCF growth 1Y424.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y774.27%
OCF growth 3YN/A
OCF growth 5Y68.98%